17 research outputs found

    Survival Of Aids Patients In The Southeast And South Of Brazil: Analysis Of The 1998-1999 Cohort [sobrevida De Pacientes Com Aids Das Regiões Sudeste E Sul Do Brasil: Análise Da Coorte De 1998-1999]

    Get PDF
    The aim of this study was to evaluate survival time for AIDS patients 13 years and older in the South and Southeast regions of Brazil, according to socio-demographic, clinical, and epidemiological characteristics. The sample was selected from all cases diagnosed in 1998 and 1999 and notified to the Epidemiological Surveillance System of the National STD/AIDS Program. Use of a questionnaire allowed analyzing 2,091 patient charts. Based on the Kaplan-Meier method, estimated survival was at least 108 months after diagnosis in 59.5% of patients in the Southeast and 59.3% in the South. Cox regression models showed, in both regions, an increase in survival in patients on antiretroviral therapy, those classified as AIDS cases according to the CD4 T-cell criterion, females, and those with more schooling. Other factors associated with longer survival in the Southeast were: white skin color, no history of tuberculosis since the AIDS diagnosis, negative hepatitis B serology, and access to a multidisciplinary health team. In the South, age below 40 years was associated with longer survival.27SUPPL. 1S79S92Fonseca, M.G.P., Bastos, F.I., Twenty-five years of the AIDS epidemic in Brazil: Principal epidemiological findings, 1980-2005 (2007) Cad Saúde Pública, (23 SUPPL 3), pp. S333-S344Boletim Epidemiológico AIDST 2008, 1. , Ministério da Saúde, Ano(2004) Critérios De Definição De Casos De AIDS Em Adultos E Crianças, , Ministério da Saúde, Brasília: Ministério da SaúdeDourado, I., Veras, M.A.S.M., Barreira, D., Brito, A.M., Tendências da epidemia de AIDS no Brasil após a terapia antirretroviral (2006) Rev Saúde Pública, (SUPPL 40), pp. 9-17Casseb, J., Fonseca, L.A., Veiga, A.P., Almeida, A., Bueno, A., Ferez, A.C., AIDS incidence and mortality in a hospital based cohort of HIV-1 seropositive patients receiving highly active antiretroviral therapy in São Paulo, Brazil (2003) AIDS Patient Care STDS, 17, pp. 447-452Crum, N.F., Riffemburg, R.H., Wegner, S., Agan, B.K., Tasker, S.A., Spooner, K.M., Comparison of causes of death and mortality rates among HIV infected persons: Analysis of the pre, early, and late HAART (highly active antiretroviral therapy) eras (2006) J Acquir Immune Defic Syndr, 41, pp. 194-200Santos, N.J.S., Tayra, A., Silva, S.R., Buchala, C.M., Laurenti, R., A AIDS no estado de São Paulo: As mudanças no perfil da epidemia e perspectivas da vigilância epidemiológica (2002) Rev Bras Epidemiol, 5, pp. 286-310Messeri, P., Lee, G., Abramson, D.M., Aidala, A., Chiasson, M.A., Jessop, D.J., Antiretroviral therapy and declining AIDS mortality in New York City (2003) Med Care, 41, pp. 512-521Vellozi, C., Brooks, J.T., Bush, T.J., Conley, L.J., Henry, K., Carperter, C.C.J., The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study) (2009) Am J Epidemiol, 169, pp. 642-652Quinn, T.C., HIV epidemiology and the effects of antiviral therapy on long term consequences (2008) AIDS, (22 SUPPL 3), pp. S7-S12Targets and Commitments Made By the Member-States At the United Nation General Assembly Special Session On HIV/AIDS, , http//www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010progr essreportssubmittedbycountries/brazil_2010_country_progress_report_en.pd f, Brazilian Ministry of Health, accessed on Jul/2010Chequer, P., Hearst, N., Hudes, E.S., Castilho, E., Rutherford, G., Loures, L., Determinants of survival in adult Brazilian AIDS patients, 1982-1989.The Brazilian State AIDS Program Co-ordinators (1992) AIDS, 6, pp. 483-487Marins, J.R., Jamal, L.E., Chen, S.Y., Barros, M.B., Hudes, E.S., Barbosa, A.A., Dramatic improvement in survival among adult Brazilian AIDS patients (2003) AIDS, 17, pp. 1675-1682Collet, D., (2003) Modeling Survival Data In Medical Research, , 2nd Ed. Boca Raton: Chapman & HallEpidemiology of HIV/AIDS, United States, 1981-2005 (2006) MMWR Morb Mortal Wkly Rep, 55, pp. 589-592. , Centers for Disease Control and PreventionWong, K.H., Chan, K.C., Lee, S.S., Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy (2004) Clin Infect Dis, 39, pp. 853-860Gadelha, A.J., Accacio, N., Costa, R.L.B., Galhardo, M.C., Cotrim, M.R., Souza, R.V., Morbidity and survival in advanced AIDS in Rio de Janeiro, Brazil (2002) Rev Inst Med Trop São Paulo, 44, pp. 179-186Hacker, M.A., Petersen, M.L., Enriquez, M., Bastos, F.I., Highly active antiretroviral therapy in Brazil: The challenge of universal access in a context of social inequality (2004) Rev Panam Salud Pública, 16, pp. 78-83Krishnan, S., Dunbar, M.S., Minnis, A.M., Medlin, C.A., Gerdts, C.E., Padian, N.S., Poverty, gender inequalities and women's risk of Human Immunodeficiency Virus/AIDS (2008) Ann N Y Acad Sci, 1136, pp. 101-110Antunes, J.L.F., Waldman, E.A., Borrel, C., Is it possible to reduce AIDS death without reinforcing socioeconomic inequalities in health? (2005) Int J Epidemiol, 34, pp. 586-592Castilho, E.A., Szwarcwald, C.L., Brito, A.M., Fatores associados à interrupção de tratamento anti-retroviral em adultos com AIDS, Rio Grande do Norte, Brasil, 1999-2002 (2006) Rev Assoc Med Bras (1992), 52, pp. 86-92Neme, M.I.B., Carvalho, H.B., Souza, M.F.M., ARV therapy adherence in Brazil (2004) AIDS, (18 SUPPL 3), pp. 515-520Pérez-Hoyos, S., Amo, J., Muga, R., Romero, J., Olalla, P.G., Guerrero, R., Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: Differences by transmission category (2003) AIDS, 17, pp. 353-359Porta, D., Forastiere, F., Fusco, D., Perucci, C.A., Lazio AIDS Surveillance Collaborative Group. Socioeconomic status and survival of persons with AIDS before and after introduction of Highly Active Antiretroviral Therapy (2000) Epidemiology, 11, pp. 496-501. , Rapiti EPrograma Nacional DST E AIDS, , http://www.aids.gov.br/cgi/deftohtm.exe?tabnet/aids.def, Ministério da Saúde, accessed on 26/Aug/2009Giovanetti, M.C., Santos, N.J.S., Westin, C.P., Darré, D., Gianna, M.C., A implantação do quesito cor/raça nos serviços de DST/AIDS no Estado de São Paulo (2007) Saúde Soc, 16, pp. 163-170Fry, P.H., Monteiro, S., Maio, M.C., Bastos, F.I., Santos, R.V., AIDS tem cor ou raça? Interpretação de dados e formulação de políticas de saúde no Brasil (2007) Cad Saúde Pública, 23, pp. 497-523Batista, L.E., (2002) Mulheres E Homens Negros: Saúde, Doença E Morte [Doctoral Dissertation], , Araraquara: Fa-culdade de Ciências e Letras, Universidade Estadual PaulistaFonseca, M.G.P., Lucena, F.F.A., Souza, A., Bastos, F.I., AIDS mortality, "race or color", and social inequality in a context of universal access to highly active antiretroviral therapy (HAART) in Brazil, 1999- 2004 (2007) Cad Saúde Pública, (23 SUPPL 3), pp. S445-S455Marins, J.R.P., (2004) Estudo De Sobrevida Dos Pacientes De AIDS Segundo Escolaridade, Co-infecção Hepatite C E Tuberculose. Coorte Brasileira 1995-1996 [Doctoral Dissertation], , Campinas: Faculdade de Ciências Médicas, Universidade Estadual de CampinasFerreira, M.S., Borges, A.S., Avanços no tratamento da hepatite pelo vírus B (2007) Rev Soc Bras Med Trop, 40, pp. 451-462Mussini, C., Manzardo, C., Johnson, M., Monforte, A., Uberti-Foppa, C., Antinori, A., Patients presenting with AIDS in the HAART era: A collaborative cohort analysis (2008) AIDS, 22, pp. 2461-2469Nemes, M.I.B., Alencar, T.M.D., (2008) Equipe Qualiaids. Avaliação Da Assistência Ambulatorial Aos Adultos Vivendo Com HIV/AIDS, , Qualiaids. Relatório 2007/2008. Brasília: Ministério da SaúdeMelchior, R., Nemes, M.I.B., Basso, C.R.B., Castanheira, E.R.L., Alves, M.T.S.B., Buchalla, C.M., Avaliação da estrutura organizacional assistência ambulatorial em HIV/AIDS no Brasil (2006) Rev Saúde Pública, 40, pp. 143-15

    Relação entre a cobertura da Estratégia Saúde da Família e o diagnóstico de sífilis na gestação e sífilis congênita Coverage by the Family Health Strategy and diagnosis of syphilis in pregnancy and congenital syphilis

    No full text
    Este estudo procurou correlacionar as informações disponíveis em sistemas nacionais de informação em saúde sobre notificações de sífilis em gestante, sífilis congênita e cobertura populacional da Estratégia Saúde da Família (FHS). As estimativas de notificação foram calculadas de acordo com o Estudo Sentinela Parturiente de 2004 do Ministério da Saúde e os dados observados foram obtidos na Internet, nas páginas da Secretaria de Vigilância em Saúde e da Secretaria de Atenção em Saúde, para o ano de 2008. As razões observadas sobre estimadas para sífilis em gestante e sífilis congênita e a cobertura populacional da FHS por macrorregião brasileira não apresentaram correlação (r = -0,28 e r = -0,40, respectivamente). A FHS se apresenta como local privilegiado para realização do pré-natal e, logicamente, fonte da notificação compulsória de sífilis em gestante. Acoplando diagnóstico com o tratamento adequado da sífilis na gestante e no parceiro, a FHS é instrumento primordial para a eliminação da sífilis congênita no Brasil. Expansão da cobertura e cuidado de qualidade são essenciais para o alcance da meta.<br>This paper aimed to correlate syphilis in pregnancy and congenital syphilis with coverage of the Family Health Strategy (FHS), based on available data in the national health information systems. The syphilis notification estimates were calculated according to the Sentinel Childbirth Study for 2004 under the Ministry of Health and the data were obtained from the websites of the Health Surveillance Secretariat and Healthcare Secretariat, for the year 2008. The ratios between observed and estimated gestational syphilis and congenital syphilis were not statistically correlated with population coverage by the FHS (r = -0.28 and r = -0.40, respectively). The FHS is a privileged area for prenatal care and logically a source of compulsory notification of syphilis in pregnancy. By combining diagnosis with adequate treatment of syphilis in pregnant women and their partners, the FHS becomes a prime instrument for eliminating congenital syphilis in Brazil. Expanding the FHS coverage and quality of care are essential for achieving this goal
    corecore